B · Normal
On November 12, sources and documents showed that the U.S. FDA had shelved the fast-track drug review plan initiated by former Commissioner Macari.
Related telegraphs
[U.S. FDA terminates rapid drug review program] November 12th, the U.S. Food and
11-12 19:50
On November 12, Eli Lilly’s stock price rose 3% before the market opened as Chin
11-12 17:55
[Henan issues notice to further standardize centralized drug procurement] On Nov
11-12 16:25
On November 12, Hungarian pharmaceutical company Gilead (Richter) signed a women
11-12 15:12
[Yunnan: Explore the development of “TCM + AI” and promote the application of TC
11-12 11:47
[Fujian: Build 10 artificial intelligence scientific research and innovation pla
11-12 11:25
Comments